CJC 1295 (no DAC) + Ipamorelin
CJC-1295 (No DAC) + Ipamorelin
Dual Growth Hormone Signaling Research Blend
CJC-1295 (No DAC) + Ipamorelin is a peptide combination commonly studied for its role in growth hormone signaling and endocrine system regulation. This research blend pairs two peptides that interact with different receptors involved in the body’s natural growth hormone release cycle. By working through complementary pathways, this combination allows researchers to investigate how growth hormone secretion may be stimulated while maintaining natural feedback mechanisms within the endocrine system.
Because of its targeted interaction with growth hormone pathways, this peptide blend has become widely studied in metabolic, recovery, and hormone regulation research models.
Mechanism of Action
Each peptide in this blend contributes to stimulating growth hormone signaling through different biological mechanisms.
CJC-1295 (No DAC)CJC-1295 without DAC is a modified analog of growth hormone-releasing hormone (GHRH). In research models, it binds to receptors in the pituitary gland, stimulating the release of growth hormone through the body’s natural endocrine signaling pathways.
IpamorelinIpamorelin is a selective growth hormone secretagogue that works by activating the ghrelin receptor (GHS-R1a). This interaction can promote additional growth hormone release while showing minimal activity on other hormones commonly affected by earlier secretagogues.
When studied together, these peptides allow researchers to explore how stimulating both GHRH receptors and ghrelin receptors may influence pulsatile growth hormone release.
Research Findings
Laboratory investigations involving CJC-1295 (No DAC) and Ipamorelin have examined their combined effects on growth hormone signaling and metabolic regulation. Research suggests the peptides may influence growth hormone and IGF-1 pathways, which are involved in cellular repair, metabolic activity, and tissue maintenance.
Scientists often study this combination to better understand how growth hormone pulses are regulated within the hypothalamic-pituitary axis and how these signals influence broader physiological systems.
Potential Research Applications
Current research involving CJC-1295 (No DAC) + Ipamorelin may focus on:
• Growth hormone signaling pathways• Hypothalamic-pituitary endocrine research• Metabolic and energy regulation studies• Tissue regeneration and recovery research models• Hormonal signaling and IGF-1 pathway investigation
Product Quality
• High-purity lyophilized peptide blend• Research-grade manufacturing standards• Stable vial formulation for laboratory research environments
Research Use Only
This product is intended strictly for laboratory research purposes only and is not approved for human or veterinary use. Any information presented is for educational and scientific discussion within research environments.